Another hepatocytes experiment in vitro showed that Rbm15 silencing improved insulin sensitivity by increasing AKT phosphorylation, whereas Rbm15 overexpression had the opposite effect (86) (We need to emphasize here again that T2D patients are at low m6A modification overall, but high m6A abundance in the liver). The gene discussed is AKT1; the disease is type 2 diabetes mellitus.